Literature DB >> 20094812

The impact of intestinal failure on oral drug absorption: a review.

Nicola Ward1.   

Abstract

INTRODUCTION: Intestinal failure is a complex gastroenterological condition that occurs as a result of reduced intestinal absorption of nutrients and/or water and electrolytes. Without treatment, nutritional depletion and/or dehydration will result. It can be acute or chronic and occurs secondary to a variety of causes, including massive bowel resection, inflammatory bowel diseases of the bowel, and small bowel dysfunction. RESULTS AND DISCUSSION: Resection of the small bowel results in a range of physiological changes that affect the absorption of nutrients, water, and electrolytes. In addition, these changes may also affect the absorption of orally administered medication. However, there is only minimal published literature regarding this, with the publications limited to case reports of failure or efficacy of certain medicines such as digoxin and warfarin in individual patients. Due to the highly heterogeneous nature of intestinal failure patients, there is little generalizability of the information within these articles to other patients. Only one article seeks to provide limited practical advice regarding prescribing in this complex patient group.
CONCLUSION: The input of specialist pharmacists is necessary in the management of these patients to ensure that appropriate drugs and formulations are prescribed in a timely manner to optimize absorption and resultant efficacy.

Entities:  

Mesh:

Year:  2010        PMID: 20094812     DOI: 10.1007/s11605-009-1151-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  34 in total

1.  American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation.

Authors: 
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

2.  Pharmacokinetics of tacrolimus and cyclosporine in short-bowel syndrome.

Authors:  J Thielke; J Martin; F L Weber; T J Schroeder; S Goretsky; D W Hanto
Journal:  Liver Transpl Surg       Date:  1998-09

3.  Nortriptyline absorption in short bowel syndrome.

Authors:  J E Broyles; R O Brown; T H Self; R C Frederick; R W Luther
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 May-Jun       Impact factor: 4.016

4.  Digoxin absorption in a patient with short-bowel syndrome.

Authors:  S J Vetticaden; M E Lehman; G R Barnhart; W H Barr
Journal:  Clin Pharm       Date:  1986-01

5.  Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia.

Authors:  G P Bongaerts; J J Tolboom; A H Naber; W J Sperl; R S Severijnen; J A Bakkeren; J L Willems
Journal:  Microb Pathog       Date:  1997-05       Impact factor: 3.738

6.  [Bioavailability of sotalol in short bowel syndrome].

Authors:  M Silomon; F Bach; S Juckenhöfel; T Claus; G Molter
Journal:  Med Klin (Munich)       Date:  1999-11-15

7.  Warfarin absorption after massive small bowel resection.

Authors:  D M Lutomski; R J LaFrance; R H Bower; J E Fischer
Journal:  Am J Gastroenterol       Date:  1985-02       Impact factor: 10.864

8.  Bioavailability of oral antibiotics in children with short-bowel syndrome.

Authors:  G Menardi; J P Guggenbichler
Journal:  J Pediatr Surg       Date:  1984-02       Impact factor: 2.545

9.  Study of the bioavailability of pindolol in malabsorption syndromes.

Authors:  D Evard; J P Aubry; Y Le Quintrec; G Cheymol; A Cheymol
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

10.  Absorption of orally administered digoxin after massive resection of the small bowel.

Authors:  M M Krausz; E Berry; U Freund; M Levy
Journal:  Am J Gastroenterol       Date:  1979-02       Impact factor: 10.864

View more
  6 in total

Review 1.  Biomagnetic methods: technologies applied to pharmaceutical research.

Authors:  Luciana A Corá; Madileine F Américo; Ricardo B Oliveira; Cristina H R Serra; Oswaldo Baffa; Raul C Evangelista; Giselle F Oliveira; José Ricardo Aruda Miranda
Journal:  Pharm Res       Date:  2010-10-15       Impact factor: 4.200

2.  Improvement of paracellular transport in the Caco-2 drug screening model using protein-engineered substrates.

Authors:  Rebecca L DiMarco; Daniel R Hunt; Ruby E Dewi; Sarah C Heilshorn
Journal:  Biomaterials       Date:  2017-03-18       Impact factor: 12.479

3.  Systematic review of drug bioavailability following gastrointestinal surgery.

Authors:  Manuela Moreno Santamaría; José Javier Arenas Villafranca; Jimena Abilés; Alberto Fernández López; Lucia Visiedo Rodas; Begoña Tortajada Goitia; Pilar Utrilla Navarro
Journal:  Eur J Clin Pharmacol       Date:  2018-08-22       Impact factor: 2.953

4.  Characterizing drug-metabolizing enzymes and transporters that are bona fide CAR-target genes in mouse intestine.

Authors:  Shinhee Park; Sunny Lihua Cheng; Julia Yue Cui
Journal:  Acta Pharm Sin B       Date:  2016-08-02       Impact factor: 11.413

5.  Therapeutic Drug Monitoring of Anti-human Immunodeficiency Virus Drugs in a Patient with Short Bowel Syndrome.

Authors:  Motoko Ikuma; Dai Watanabe; Hiroki Yagura; Misa Ashida; Masaaki Takahashi; Masaaki Shibata; Tadafumi Asaoka; Munehiro Yoshino; Tomoko Uehira; Wataru Sugiura; Takuma Shirasaka
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

6.  A fast screening model for drug permeability assessment based on native small intestinal extracellular matrix.

Authors:  Na Li; Zhigang Sui; Yong Liu; Dandan Wang; Guangbo Ge; Ling Yang
Journal:  RSC Adv       Date:  2018-10-08       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.